Datwyler one of the leading manufacturers of elastomer components for pharmaceutical packaging is expanding its portfolio with two new products to meet evolving patient demands. The new offerings include a 5 and 8 inches rigid needle shield (RNS) to address the rising need for prefilled syringes to contain vaccines for intramuscular injection and isoprene rubber discs for infusion therapies.
Datwyler’s new 5 and 8 inches RNS answers the call for solutions to increasingly urgent challenges posed by the ongoing pandemic. The onset of Covid-19 has accelerated growth in demand for prefilled syringes and correlating needle shields. The prefilled syringes market is now expected to grow around 13% in the period 2021-2025 reaching a volume of 7.5bn units provided at the global level at the end of 2025. During the same period, the 5 and 8 in. RNS market is expected to grow around 25%, reaching a volume of 1.75bn units provided at the global level at the end of 2025.
Datwyler’s 5 and 8 inches RNS is designed with a best-in-class rubber formulation known as FM30. FM30 enables worldwide regulatory compliance with a low extractable profile and an adequate gas permeability that allows ETO sterilization and facilitates controlled pull-off force, high separation force, and excellent seal integrity. The design is also compatible with standard PFS and runs on standard syringe assembly lines with no necessary changes.
Additionally, Datwyler’s introduction of isoprene rubber discs will also help meet the demand for the packaging of a wide range of infusion therapies.
“This product is an excellent addition to Datwyler’s parenteral packaging portfolio,” said, Howie Yang, head of Market Development China.
